Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zsófia Ilona, Szojka"'
Autor:
Mohamed Mahdi, János András Mótyán, Zsófia Ilona Szojka, Mária Golda, Márió Miczi, József Tőzsér
Publikováno v:
Virology Journal, Vol 17, Iss 1, Pp 1-8 (2020)
Abstract Background The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in millions of infections worldwide. While the search for an effective antiviral is still ongoing, experimental therapies based on re
Externí odkaz:
https://doaj.org/article/d94cae4114864d588b2957c2e249cfa4
Autor:
Dawit Assefa Arimide, Zsófia Ilona Szojka, Kidist Zealiyas, Atsbeha Gebreegziabxier, Fekadu Adugna, Sviataslau Sasinovich, Per Björkman, Patrik Medstrand
Publikováno v:
Viruses, Vol 14, Iss 4, p 729 (2022)
Dolutegravir-based antiretroviral therapy (ART) has been scaled up in many developing countries, including Ethiopia. However, subtype-dependent polymorphic differences might influence the occurrence of HIV-drug-resistance mutations (HIVDRMs). We anal
Externí odkaz:
https://doaj.org/article/04fe20489c554b5498aa39fb40ce29ef
Autor:
Tamás Richárd Linkner, Viktor Ambrus, Balázs Kunkli, Zsófia Ilona Szojka, Gergő Kalló, Éva Csősz, Ajneesh Kumar, Miklós Emri, József Tőzsér, Mohamed Mahdi
Publikováno v:
Microorganisms, Vol 9, Iss 11, p 2207 (2021)
Lentivirus-based vectors derived from human immunodeficiency viruses type 1 and 2 (HIV-1 and 2) are widely used tools in research and may also be utilized in clinical settings. Like their parental virions, they are known to depend on the cellular mac
Externí odkaz:
https://doaj.org/article/33fd90d04c0d4d0c845561ded4000293
Publikováno v:
Proceedings, Vol 50, Iss 1, p 24 (2020)
Human immunodeficiency viruses type 1 and 2 (HIV-1 and HIV-2) are the causative agents of the acquired immunodeficiency syndrome (AIDS). While both viruses share a similar structural and genomic organization, a difference in replication dynamics and
Externí odkaz:
https://doaj.org/article/ba27d6a6c3af4f3788e694244ee9a05c
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 9; Pages: 4766
HIV-2, compared to HIV-1, elicits potent and broadly neutralizing antibodies, and uses a broad range of co-receptors. However, both sensitivity to neutralization and breadth of co-receptor use varies between HIV-2 isolates, and the molecular backgrou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::9eed5b37ea92ee6995f66f62dfac5761
Autor:
Zsófia Ilona, Szojka, Sara, Karlson, Emil, Johansson, Gülşen Özkaya, Şahin, Marianne, Jansson
Publikováno v:
International journal of molecular sciences. 23(9)
HIV-2, compared to HIV-1, elicits potent and broadly neutralizing antibodies, and uses a broad range of co-receptors. However, both sensitivity to neutralization and breadth of co-receptor use varies between HIV-2 isolates, and the molecular backgrou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7dbc2659f884347189a7f18a2fd59dfd
https://pubmed.ncbi.nlm.nih.gov/35563157
https://pubmed.ncbi.nlm.nih.gov/35563157